Four prominent Indian companies—Awfis Space Solutions Ltd, Blue Jet Healthcare Ltd, Surya Roshni Ltd, and TVS Supply Chain Solutions Ltd—witnessed their stock prices climb by 5-19% in recent trading sessions. This significant rally follows the announcement of their robust financial performance for the March quarter, which largely exceeded market expectations.
Awfis Space Solutions Leads the Gains
Awfis Space Solutions saw its shares soar by 19.05%, reaching a high of Rs 428.35. The company's March quarter profit surged by an impressive 107% year-on-year to Rs 23 crore. Operating revenue also demonstrated strong growth, increasing by 21% year-on-year to Rs 410 crore, primarily driven by a 27% growth in its Coworking and allied services segment. Awfis reported a 31% year-on-year growth in operating EBITDA to Rs 152 crore, with its operating margin expanding by 290 basis points to 37%. This improvement reflects enhanced scale efficiencies, a greater contribution from mature centers, and operational leverage. Chairman and Managing Director, Amit Ramani, expressed confidence, stating the business is in its strongest position entering FY27 with healthy occupancy, expanding margins, and an industry-leading return on capital.
Surya Roshni Reports Strong Profit Growth
Surya Roshni's shares advanced by 7.17% to Rs 233. The company announced a 23% sequential jump in its Q4 profit, reaching Rs 98 crore, despite ongoing pricing pressures across various segments. For FY27, Surya Roshni is targeting significant operational improvements, including a newly commissioned testing and manufacturing facility at its Kashipur unit. This facility is expected to reduce import dependency, shorten response times, and improve cost efficiency. The company is also developing BLDC-based fan solutions and advancing its premiumization strategy in select appliance categories. Distribution expansion is a key focus, with targets to reach 3 lakh billing points by March 2028 and 4 lakh by March 2030. Additionally, Surya Roshni is evaluating higher-margin adjacencies like solar wires and cables, and motor-winding wire to broaden its product portfolio and margin profile.
Blue Jet Healthcare Exceeds Analyst Estimates
Blue Jet Healthcare shares climbed 6.73% to Rs 515. The company's Q4 EBITDA surpassed analyst estimates by 20%, despite negligible pharma intermediate (PI) sales during the quarter. This beat was primarily attributed to a sharp increase in contrast media intermediate (CMI) sales and a subsequent higher gross margin. Management commentary indicated an upbeat outlook for topline growth, projecting double-digit growth in CMI sales for FY27 and PI sales exceeding FY25 levels in FY27. Emkay Global raised its target price on the stock by 12.5% to Rs 450, while MOFSL suggested a target of Rs 580, anticipating a recovery in pharma intermediates and strong momentum in contrast media through new launches and capacity expansion.
TVS Supply Chain Solutions Returns to Profitability
TVS Supply Chain Solutions saw its shares rise by 4.96% to Rs 126.95. The company reported a net profit of Rs 18.4 crore for the March quarter, a significant turnaround from a loss of Rs 3.9 crore in the same period last year. Consolidated revenue from operations increased by 21.3%, with adjusted EBITDA growing by 37.5%. In a leadership transition, the board noted the resignation of Ravi Viswanathan as Managing Director, effective June 30, 2026. Vikas Chadha, currently Global CEO, has been approved to take over as Managing Director from July 1, 2026.